NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].
Show details| Days After Starting | Days After Stopping | ALT (U/L) | Alk P (U/L) | Bilirubin (mg/dL) | Other |
|---|---|---|---|---|---|
| 6 months | 0 | 916 | 462 | 15.1 | Admission, 2 weeks after onset of symptoms. R=13.8 |
| 7 months | 28 days | 467 | 670 | 23.8 | R=4.2 |
| 7.5 months | 38 days | 186 | 769 | 10.5 | R=1.7 |
| 8 months | 51 days | 104 | 458 | 3.1 | |
| 10 months | 110 days | 28 | 234 | 0.5 | Asymptomatic |
| Normal Values | <40 | <280 | <1.2 | ||
- "Hepatotoxicity in inflammatory bowel disease: mesalazine, the forgotten drug".[Eur J Gastroenterol Hepatol. 2...]"Hepatotoxicity in inflammatory bowel disease: mesalazine, the forgotten drug".Garrido I, Santos AL, Lopes J, Lopes S, Macedo G. Eur J Gastroenterol Hepatol. 2021 Dec 1; 33(1S Suppl 1):e1067-e1070.
- Review Review article: high-dose aminosalicylates to induce and maintain remissions in ulcerative colitis.[Aliment Pharmacol Ther. 2006]Review Review article: high-dose aminosalicylates to induce and maintain remissions in ulcerative colitis.Hanauer SB. Aliment Pharmacol Ther. 2006 Oct; 24 Suppl 3:37-40.
- Review Balsalazide disodium for the treatment of ulcerative colitis.[Expert Rev Gastroenterol Hepat...]Review Balsalazide disodium for the treatment of ulcerative colitis.Patil SA, Moss AC. Expert Rev Gastroenterol Hepatol. 2008 Apr; 2(2):177-84.
- Review Review article: aminosalicylates in inflammatory bowel disease.[Aliment Pharmacol Ther. 2004]Review Review article: aminosalicylates in inflammatory bowel disease.Hanauer SB. Aliment Pharmacol Ther. 2004 Oct; 20 Suppl 4:60-5.
- Oral versus combination mesalazine therapy in active ulcerative colitis: a double-blind, double-dummy, randomized multicentre study.[Aliment Pharmacol Ther. 2001]Oral versus combination mesalazine therapy in active ulcerative colitis: a double-blind, double-dummy, randomized multicentre study.Vecchi M, Meucci G, Gionchetti P, Beltrami M, Di Maurizio P, Beretta L, Ganio E, Usai P, Campieri M, Fornaciari G, et al. Aliment Pharmacol Ther. 2001 Feb; 15(2):251-6.
- [Table, Laboratory Values]. - LiverTox[Table, Laboratory Values]. - LiverTox
Your browsing activity is empty.
Activity recording is turned off.
See more...